Westpac Banking Corp Invests $473,000 in Agilent Technologies, Inc. $A

Westpac Banking Corp purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 3,558 shares of the medical research company’s stock, valued at approximately $473,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Fiduciary Trust Co boosted its holdings in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares in the last quarter. Sapient Capital LLC increased its holdings in Agilent Technologies by 4.2% in the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after buying an additional 85 shares in the last quarter. Plan A Wealth LLC increased its holdings in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after buying an additional 92 shares in the last quarter. UNIVEST FINANCIAL Corp lifted its position in shares of Agilent Technologies by 1.3% during the 2nd quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock valued at $949,000 after acquiring an additional 93 shares during the period. Finally, IHT Wealth Management LLC lifted its position in shares of Agilent Technologies by 4.9% during the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares during the period.

Agilent Technologies Price Performance

NYSE:A opened at $159.25 on Friday. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.51. The firm has a market cap of $44.98 billion, a price-to-earnings ratio of 31.98, a price-to-earnings-growth ratio of 2.81 and a beta of 1.25. The company’s 50-day moving average is $137.57 and its two-hundred day moving average is $126.23. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price target for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Morgan Stanley upped their target price on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target for the company. Finally, HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.